IPRASENSE
PrivateLast Round
Grant
Nov 1, 2021
Total Funding Raised
$1.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
IPRASENSE operates in Healthcare & Life Sciences and is based in Clapiers. Its latest recorded funding round was a Grant round in November 2021.
IPRASENSE is a life sciences company that develops and commercializes innovative cell culture monitoring equipment, including automated cell counters and viability analyzers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IPRASENSE Comparables
Compare IPRASENSE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phase Holographic Imaging AB | 81% | |
| Aligned Genetics | 79% | |
| Nanolive SA | 77% |
For institutional investors. Book with your work email.
IPRASENSE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2021 | ||||
| Accelerator | Jul 1, 2019 | ||||
| Grant | May 1, 2018 |
For institutional investors. Book with your work email.
IPRASENSE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovative Health Initiative | Grant |
| European Commission | Grant |
| SATT AxLR | Accelerator |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 2, representing 67% of headcount.
- Jul 2, 2025
Monthly visitors increased 49% MoM.
For institutional investors. Book with your work email.
IPRASENSE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IPRASENSE's valuation, stock price, and market status.
Is IPRASENSE a public or private company?
IPRASENSE is a private company.
What is the current stock price of IPRASENSE?
IPRASENSE is a private company, so its shares have no public market price. Caplight tracks IPRASENSE's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IPRASENSE worth (valuation)?
Valuation information for IPRASENSE is not publicly available.
Can I buy IPRASENSE stock?
IPRASENSE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IPRASENSE's last funding round?
IPRASENSE's most recent funding round was Grant on November 1, 2021.
Who are the main investors in IPRASENSE?
Key investors in IPRASENSE include Innovative Health Initiative, SATT AxLR, Bpifrance.
Will IPRASENSE IPO soon?
No public IPO plans have been announced for IPRASENSE.
How can I track IPRASENSE secondary market activity?
Caplight tracks bids, offers, and trades in IPRASENSE's shares on secondary markets.